| Financial Year |
March 31 2023 |
| Monetary Funds |
395,196,574.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
105,705,144.78 |
| Advances to Suppliers |
171,819,999.61 |
| Other Receivables |
7,426,695.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
177,199,565.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,144,979.43 |
| Total Current Assets |
866,492,959.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,810,049.67 |
| Investment Properties |
-- |
| Fixed Assetes |
181,317,938.53 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,769,166.62 |
| R&D expenses |
-- |
| Goodwill |
9,154,594.69 |
| Long-Term Deferred and Prepaid Expenses |
3,769,906.71 |
| Deferred Income Tax Assets |
23,096,467.04 |
| Other Non-Current Assets |
3,194,193.00 |
| Sub-Total of Non-Current Assets |
308,480,969.80 |
| Total Assets |
1,174,973,929.35 |
| Short-Term Loans |
20,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,246,844.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,244,028.31 |
| Taxes Payable |
1,211,335.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,421,940.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,266,307.17 |
| Other Current Liabilities |
539,480.77 |
| Sub-Total of Current Liabilities |
80,411,220.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,321,000.51 |
| Deferred Income Tax Liabilities |
1,295,906.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,762,204.35 |
| Total Liabilities |
91,173,425.32 |
| Paid-In Capital(Or Share Stock) |
121,699,840.00 |
| Capital Surplus |
616,421,045.12 |
| Surplus Reserve |
17,242,366.26 |
| LESS:Treasury Stock |
6,028,656.13 |
| Undistributed Profits |
334,538,040.56 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,083,800,504.03 |
| Owner's Equity（Stockholder's Equity） |
1,083,800,504.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,174,973,929.35 |
